Brain injection trial tests new gene therapy for Parkinson's
NCT ID NCT06480461
Summary
This early-stage study is testing a new gene therapy, VGN-R09b, for Parkinson's disease. It aims to see if the treatment is safe and if it can help control motor symptoms in people whose current medications aren't working well enough. The therapy is delivered via a one-time injection directly into the brain.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PARKINSON'S DISEASE are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Shanghai
Shanghai, Shanghai Municipality, 200120, China
Conditions
Explore the condition pages connected to this study.